Children’s Cancer Institute shared a post on LinkedIn:
“We’re thrilled to share that Chelsea Mayoh has been selected as the 2025 Rising Star PhD Candidate at the NSW Premier’s Awards for Outstanding Cancer Research hosted by Cancer Institute NSW.
This prestigious event pays tribute to the remarkable accomplishments of individuals and teams within the cancer research community and those supporting innovation and cutting-edge delivery of care.
A PhD Student at Children’s Cancer Institute, Chelsea leads the Bioinformatics team and is Computational Transcriptomics Leader for the Zero Childhood Cancer Program (ZERO). Her pioneering research in paediatric cancer genomics is transforming precision oncology in Australia.
ZERO is a world-leading national precision medicine program for children and young people with cancer led by Children’s Cancer Institute and Kids Cancer Centre at Sydney Children’s Hospital, Randwick.
Providing in-depth genomic analysis for each child enrolled, ZERO is not only improving outcomes for children being treated for cancer today but is also advancing science’s understanding of childhood cancer for the benefit of all
A huge congratulations to Chelsea for this recognition of your outstanding contribution to ZERO and for everything you’re doing to reshape the future for children with cancer in Australia.”
More from Children’s Cancer Institute.